US EditionAbbVie Inc. (NYSE:ABBV) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
AbbVie Inc. (NYSE:ABBV) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twenty-seven ratings firms that are currently covering the stock, Marketbeat reports. Eight research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have given a strong buy […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
